However, the documented function of NFκB adjustment in physiological adaptive processes underscores its pivotal involvement in cancer development, progression, and resistance to therapy, when feedback or general restriction to NFκB is impaired [111,114,183,184]. The gene discussed is NFKB1; the disease is cancer.